Corient Private Wealth LP Boosts Holdings in Agilent Technologies, Inc. $A

Key Points

• Corient Private Wealth increased its Agilent Technologies stake by 8.5% in the second quarter, bringing its holdings to 240,532 shares valued at approximately $32.0 million.
• Agilent reported quarterly EPS of $1.62 and revenue of $1.88 billion, exceeding analyst estimates, while revenue grew 8.1% year over year. The company guided for fiscal 2026 EPS of $6.18–$6.21.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $170.33, compared with the stock’s reported price of $146.91.

Corient Private Wealth LP lifted its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.5% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 240,532 shares of the medical research company's stock after acquiring an additional 18,901 shares during the quarter. Corient Private Wealth LP owned 0.09% of Agilent Technologies worth $31,952,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. SHP Wealth Management bought a new stake in Agilent Technologies in the fourth quarter worth $26,000. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies during the fourth quarter valued at about $26,000. Markowski Investments purchased a new stake in Agilent Technologies during the second quarter valued at about $27,000. MV Capital Management Inc. bought a new position in shares of Agilent Technologies during the fourth quarter valued at about $28,000. Finally, Entrust Financial LLC bought a new position in shares of Agilent Technologies during the fourth quarter valued at about $31,000.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $146.91 on Monday. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The firm has a market cap of $41.42 billion, a P/E ratio of 28.92, a P/E/G ratio of 2.24 and a beta of 1.24. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75. The firm has a 50-day moving average of $143.71 and a 200-day moving average of $128.65.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.Agilent Technologies's revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on A shares. Barclays boosted their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an "overweight" rating in a research note on Thursday, August 27th. JPMorgan Chase & Co. raised their price target on Agilent Technologies from $180.00 to $190.00 and gave the stock an "overweight" rating in a research report on Thursday, August 27th. TD Cowen lifted their price target on Agilent Technologies from $155.00 to $180.00 and gave the stock a "buy" rating in a research note on Thursday, August 27th. UBS Group initiated coverage on Agilent Technologies in a research note on Wednesday, September 9th. They set a "neutral" rating and a $165.00 price objective for the company. Finally, Wolfe Research reissued a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $170.33.

Insider Buying and Selling at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the business's stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares of the company's stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.